Table 1.
Correlation Between circZNF609 Expression and the Clinicopathological Features of NSCLC Patients
| Characteristics | Cases (n) | circZNF609 Expression | P-value | ||
|---|---|---|---|---|---|
| High (n = 31) | Low (n = 31) | ||||
| Gender | 0.349 | ||||
| Male | 49 | 23 | 26 | ||
| Female | 13 | 8 | 5 | ||
| Age (years) | 0.587 | ||||
| < 60 | 42 | 20 | 22 | ||
| ≥60 | 20 | 11 | 9 | ||
| Smoking status | 0.303 | ||||
| Smokers | 36 | 20 | 16 | ||
| No-smokers | 26 | 11 | 15 | ||
| Histological type | 0.812 | ||||
| Adenocarcinoma | 34 | 16 | 18 | ||
| Squamous cell carcinoma | 21 | 12 | 9 | ||
| Large cell | 7 | 3 | 4 | ||
| Differentiation | 0.602 | ||||
| Well/Moderate | 38 | 18 | 20 | ||
| Poor | 24 | 13 | 11 | ||
| Lymph node metastasis | 0.022* | ||||
| No | 29 | 10 | 19 | ||
| Yes | 33 | 21 | 12 | ||
| TNM stages | 0.041* | ||||
| I/II | 24 | 13 | 21 | ||
| III | 28 | 18 | 10 | ||
Note: *P <0.05.
Abbreviation: TNM, tumor-node-metastasis.